Human Influenza A(H3N2) virus, A/France/PDL-IPP08331/2025, epidemic isolate, J.2.4.1 alias K subclade
virus

Human Influenza A(H3N2) virus, A/France/PDL-IPP08331/2025, epidemic isolate, J.2.4.1 alias K subclade

REFERENCE STRAIN

EVAg
Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
017V-06286
Human Influenza A(H3N2) virus, J.2.4.1 alias K subclade, A/France/PDL-IPP08331/2025, isolate of 2025-2026 epidemic season
Product Risk Group: 
RG2
ICTV Taxonomy: 
Riboviria / Orthornavirae / Negarnaviricota / Polyploviricotina / Insthoviricetes / Articulavirales / Orthomyxoviridae / Alphainfluenzavirus / Influenza A virus
Virus name: 
Influenza A virus
Strain: 
A/France/PDL-IPP08331/2025
Genotype: 
3C.2a1b.2a.2a.3a.1
Serotype: 
A/Valladolid/1187/2025-like

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
one vial of 500µL clarified supernatant

1 500,00 €
 (Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
Reference Strain
GMO: 
No
Biosafety restrictions: 
BSL2 procedures
Virus host type: 
Human virus
Infectivity Test: 
HA, Plaque assay
Viral titer: 
1,6.10^6 PFU/mL
Production cell line: 
MDCK cells
Virus Cultivability: 
Cultivable virus
Passage: 
C2
Shipping conditions: 
Dry ice
IATA Classification: 
Category B, UN3373

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Wednesday, 17 December, 2025
Country of collection: 
France
Suspected epidemiological origin : 
France
Pays de la Loire
Isolation host: 
Human
female
Isolation technique: 
3 days incubation in MDCK cell culture
Isolation conditions: 
35°C and 5% CO2